IRON · Disc Medicine, Inc. · Documents
$79.48
+0.55 (+0.70%)
At close · Oct 20
Return incl. dividend (before tax)
Market Cap
$3.05B
Shares
38.39M
Volume · Oct 20
2.21M
Avg daily vol (3M)
646.26K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | Disc Medicine announced positive Phase 3 APOLLO topline results for bitopertin in erythropoietic protoporphyria, meeting all primary and secondary endpoints, and plans to resubmit an NDA to the FDA by end of 2026 with a decision expected by mid-2027. | 2026-10-19 | — | |
| Investor Event Transcript | — | 2026-09-15 | 2026-09-30 | |
| Investor Event Transcript | — | 2026-09-14 | 2026-09-30 | |
| 8-K | — | 2026-09-10 | 2026-09-09 | |
| Investor Event Transcript | — | 2026-09-10 | 2026-09-30 | |
| 10-Q | — | 2026-07-30 | 2026-06-30 | |
| 8-K | — | 2026-07-30 | — | |
| 8-K | — | 2026-06-30 | 2026-06-25 | |
| 8-K | — | 2026-06-24 | 2026-06-18 | |
| Investor Event Transcript | — | 2026-06-03 | 2026-06-30 | |
| 10-Q | — | 2026-05-05 | 2026-03-31 | |
| 8-K | — | 2026-05-05 | — | |
| ARS | — | 2026-04-28 | 2025-12-31 | |
| DEFA14A | — | 2026-04-28 | — | |
| DEF 14A | — | 2026-04-28 | 2026-06-18 | |
| 8-K | — | 2026-02-27 | 2026-02-26 | |
| 8-K | — | 2026-02-26 | — | |
| 10-K | — | 2026-02-26 | 2025-12-31 | |
| 8-K | — | 2026-02-17 | — | |
| 8-K | — | 2026-02-13 | — | |
| 8-K | — | 2026-01-12 | — | |
| 8-K | — | 2025-12-08 | 2025-12-07 | |
| 8-K | — | 2025-11-06 | — | |
| 10-Q | — | 2025-11-06 | 2025-09-30 | |
| 8-K | — | 2025-10-22 | 2025-10-20 | |
| 8-K | — | 2025-10-20 | — | |
| 8-K | — | 2025-10-17 | 2025-10-16 | |
| 8-K | — | 2025-10-06 | 2025-10-03 | |
| 8-K | — | 2025-08-07 | — | |
| 10-Q | — | 2025-08-07 | 2025-06-30 | |
| 8-K | — | 2025-07-14 | 2025-07-09 | |
| 8-K | — | 2025-06-13 | 2025-06-11 | |
| 10-Q | — | 2025-05-07 | 2025-03-31 | |
| 8-K | — | 2025-05-07 | — | |
| DEF 14A | — | 2025-04-24 | 2025-06-11 | |
| DEFA14A | — | 2025-04-24 | — | |
| ARS | — | 2025-04-24 | 2024-12-31 | |
| 8-K | — | 2025-02-27 | — | |
| 10-K | — | 2025-02-27 | 2024-12-31 | |
| 8-K | — | 2025-01-24 | 2025-01-21 | |
| 8-K | — | 2025-01-21 | — | |
| 8-K | — | 2025-01-10 | — | |
| 8-K | — | 2024-12-09 | 2024-12-08 | |
| 8-K | — | 2024-11-15 | — | |
| 10-Q | — | 2024-11-12 | 2024-09-30 | |
| 8-K | — | 2024-11-12 | — | |
| 8-K | — | 2024-11-08 | 2024-11-06 | |
| 8-K | — | 2024-11-04 | — | |
| 8-K | — | 2024-10-25 | — | |
| S-3ASR | — | 2024-08-08 | — |
Showing 1–50 of 156 filings
Key facts
CIK
1816736
CUSIP
254604101
13F (30d)
12 filings
12 filers
Visit website
Investor relations